Cardiac magnetic resonance in hypertrophic cardiomyopathy: current state of the art
暂无分享,去创建一个
[1] M. Desai,et al. Management of hypertrophic cardiomyopathy. , 1993, Heart disease and stroke : a journal for primary care physicians.
[2] N. Smedira,et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. , 2009, Journal of the American College of Cardiology.
[3] M. Desai,et al. Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging. , 2009, Journal of the American College of Cardiology.
[4] N. Smedira,et al. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging , 2009, Heart.
[5] W. Manning,et al. Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy” , 2009 .
[6] Scott D Flamm,et al. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[7] B. Hamm,et al. Gender‐specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: Insights from cardiovascular magnetic resonance , 2008, European journal of heart failure.
[8] Luigi Rega,et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[9] W. Manning,et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.
[10] W. Manning,et al. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, The American journal of cardiology.
[11] Mario J. Garcia,et al. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study , 2008, The International Journal of Cardiovascular Imaging.
[12] Mario J. Garcia,et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy , 2007, Heart.
[13] M. Robson,et al. Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging , 2007, Circulation.
[14] A. Tajik,et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.
[15] Christine E Seidman,et al. A Contemporary Approach to Hypertrophic Cardiomyopathy , 2006, Circulation.
[16] M. Laakso,et al. Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene. , 2005, Radiology.
[17] Michael Jerosch-Herold,et al. Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.
[18] D. Pennell,et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I , 2005, Heart.
[19] Raad Mohiaddin,et al. How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[20] M. Götte,et al. Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy , 2005, Circulation.
[21] R. Falk,et al. Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.
[22] P. Dimitrow,et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. , 2004, Magnetic Resonance Imaging.
[23] J. Lima,et al. Cardiovascular magnetic resonance imaging: current and emerging applications. , 2004, Journal of the American College of Cardiology.
[24] D. Pennell,et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography , 2004, Heart.
[25] Richard D. White,et al. Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging , 2003, Journal of magnetic resonance imaging : JMRI.
[26] P. Elliott,et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.
[27] Daniel B Ennis,et al. Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging , 2003, Magnetic resonance in medicine.
[28] D. Pennell,et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.
[29] M. Komajda,et al. Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.
[30] F. T. ten Cate,et al. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. , 2003, Journal of the American College of Cardiology.
[31] B. Maron,et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.
[32] Heiko Mahrholdt,et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[33] R. Kim,et al. Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging , 2002, Circulation.
[34] D. Pennell,et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. , 2002, The American journal of cardiology.
[35] B. Maron. Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.
[36] B. Maron,et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[37] B. Maron,et al. Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.
[38] H. Mabuchi,et al. Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: The significance of type III and VI collagens , 2001, Clinical cardiology.
[39] P. Elliott,et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.
[40] P. Elliott,et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.
[41] M. Sherrid,et al. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. , 2000, Journal of the American College of Cardiology.
[42] B. Maron,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[43] J. Schulz-Menger,et al. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. , 2000, Circulation.
[44] H. Watkins. Sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[45] O. Simonetti,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.
[46] B. Maron,et al. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.
[47] T. Imaizumi,et al. Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy. , 1998, Journal of the American College of Cardiology.
[48] W. Mckenna,et al. Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction. , 1998, American heart journal.
[49] B. Maron,et al. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population , 1998, Heart.
[50] H. Watkins,et al. Sudden death due to troponin T mutations. , 1997, Journal of the American College of Cardiology.
[51] M. Burch,et al. Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.
[52] A. Crawley,et al. Left Ventricular Wall Thickness and Regional Systolic Function in Patients With Hypertrophic Cardiomyopathy: A Three‐dimensional Tagged Magnetic Resonance Imaging Study , 1994, Circulation.
[53] L. Axel,et al. Regional Heterogeneity of Function in Hypertrophic Cardiomyopathy , 1994, Circulation.
[54] B. Maron,et al. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. , 1993, The American journal of cardiology.
[55] W. Roberts,et al. Morphological Determinants of Echocardiographic Patterns of Mitral Valve Systolic AnteriorMotion in Obstructive Hypertrophic Cardiomyopathy , 1993, Circulation.
[56] W. Roberts,et al. Diversity of Structural Mitral Valve Alterations in Hypertrophic Cardiomyopathy , 1992, Circulation.
[57] W. Roberts,et al. Anomalous Insertion of Papillary Muscle Directly Into Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy: Significance in Producing Left Ventricular Outflow Obstruction , 1991, Circulation.
[58] H. Schulte,et al. [Hypertrophic obstructive cardiomyopathy]. , 1990, Deutsche Krankenpflegezeitschrift.
[59] M. Z. Berisso,et al. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. , 1989, The New England journal of medicine.
[60] W. Stewart,et al. Long-term follow-up of patients with left ventricular outflow tract obstruction after Carpentier ring mitral valvuloplasty. , 1988, Circulation.
[61] E. Nabel,et al. Variability of transient myocardial ischemia in ambulatory patients with coronary artery disease. , 1988, Circulation.
[62] W. Roberts,et al. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.
[63] I. Kronzon,et al. Long-term follow-up after mitral valve reconstruction: incidence of postoperative left ventricular outflow obstruction. , 1986, Circulation.
[64] R. Bonow,et al. Obstructive hypertrophic cardiomyopathy associated with minimal left ventricular hypertrophy. , 1984, American Journal of Cardiology.
[65] J. Griffith,et al. Mechanism of left ventricular outlfow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis). , 1975, The American journal of cardiology.
[66] M. Dunn,et al. Anterior‐Superior Displacement of Papillary Muscles Producing Obstruction and Mitral Regurgitation in Idiopathic Hypertrophic Subaortic Stenosis: Operative Relief by Posterior‐Superior Realignment of Papillary Muscles Following Ventricular Septal Myectomy , 1974, Circulation.
[67] L. J. Krovetz,et al. Distalward Modification of the Arterial Pulse Wave in Children with Congenital Aortic Stenosis , 1974, Circulation.
[68] C. Lambrew,et al. Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients , 1964, Circulation.
[69] N. Smedira,et al. Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: an unusual presentation of hypertrophic cardiomyopathy. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[70] N. Smedira,et al. Papillary muscle realignment for symptomatic left ventricular outflow tract obstruction. , 2008, The Journal of thoracic and cardiovascular surgery.
[71] M. Sheppard,et al. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[72] J. Schulz-Menger,et al. Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[73] L. Shaw,et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. , 2004, European heart journal.
[74] O. Simonetti,et al. An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.
[75] W. Roberts,et al. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.
[76] D J Pennell,et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[77] J. Towbin,et al. Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases : Hypertrophic Cardiomyopathy , Long-QT Syndrome , and Marfan Syndrome , 1998 .
[78] P. D. Collins,et al. Anomalous papillary muscle as a cause of left ventricular outflow tract obstruction in an adult. , 1997, The Annals of thoracic surgery.
[79] N. Krasnow. An acquired disease component in hypertrophic cardiomyopathy: new clinical clarifications. , 1989, Journal of the American College of Cardiology.